NTCOC
NXTM

Northern Trust Company of Connecticut’s NxStage Medical Inc. NXTM Stock Holding History

Northern Trust Company of Connecticut’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$312K Sell
31,235
-346
-1% -$3.93K ﹤0.01% 1675
2013
Q3 		$416K Buy
31,581
+1,399
+5% +$18.4K ﹤0.01% 1578
2013
Q2 		$431K Buy
+30,182
New +$380K ﹤0.01% 1521

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Northern Trust Company of Connecticut's NXTM Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its NxStage Medical Inc. (NXTM) stake by 1.1% in Q4 2013, selling an estimated $3.93K and leaving 31,235 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Northern Trust Company of Connecticut first reported a position in NXTM in Q2 2013 and has held it in 3 quarters since. The position peaked at $431K in Q2 2013. 114 funds tracked by Wall St. Rank hold NXTM as of Q4 2013.

  • Northern Trust Company of Connecticut held 31,235 shares of NxStage Medical Inc. worth $312K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 346 NxStage Medical Inc. shares in Q4 2013, an estimated $3.93K.
  • NxStage Medical Inc. made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1675 holding.
  • Northern Trust Company of Connecticut first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's NxStage Medical Inc. position peaked at $431K in Q2 2013.
  • 114 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.